References
- Gahl WA, Brantly M, Kaiser-Kupfer MI . 1998. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky–Pudlak syndrome). New England Journal of Medicine 338:1258–1264.
- Lee CA, Chi C, Pavord SR . 2006. The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK haemophilia centre doctors’ organization. Haemophilia 12:301–336.
- Mannucci PM. 2005. Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women. Blood 105:3382–3382.
- Poddar RK, Coley S, Pavord S. 2004. Hermansky–Pudlak syndrome in a pregnant patient. British Journal of Anaesthesia 9:740–742.
- Ray JG. 1998. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstetrical and Gynecological Survey 53:450–455.
- Witcop CJ, Krumweide N, Sedano H . 1987. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky–Pudlak syndrome. American Journal Haematology 26:305–311.
- Witkop CJ Jr, Quevedo WC, Fitzpatric TB. 1983. Albinism and other disorders of amino acid metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, editors. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill.
- Witkop CJ Jr, White JG, King RA. 1974. Oculocutaneous albinism. In: Nyhan WL, editor. Heritable disorders of amino acid metabolism. New York: John and Wiley and Sons.
- Zatik J, Poka R, Borsos A . 2002. Variable response of Hermansky–Pudlak syndrome to prophylactic administration of 1-desamino 8D-arginine in subsequent pregnancies. European Journal of Obstetrics, Gynaecology, and Reproductive Biology 104:165–166.